186 related articles for article (PubMed ID: 7067086)
1. Direct radioimmunoassays for "aldosterone" and "18-hydroxycorticosterone" in unprocessed urine, and their use in screening to distinguish primary aldosteronism from hypertension.
Vecsei P; Benraad TJ; Hofman J; Abdelhamid S; Haack D; Lichtwald K
Clin Chem; 1982 Mar; 28(3):453-6. PubMed ID: 7067086
[TBL] [Abstract][Full Text] [Related]
2. Aldosterone diagnosis in hypertension: comparative evaluation of radioimmunoassays for urinary aldosterone and 18-OH-corticosterone.
Connolly TM; Vecsei P; Haack D; Kohl KH; Abdelhamid S; Ammenti A
Klin Wochenschr; 1978; 56 Suppl 1():173-81. PubMed ID: 732248
[No Abstract] [Full Text] [Related]
3. Elevated 'free' 18-hydroxy-corticosterone excretion as a possible indicator for early diagnosis of primary aldosteronism.
Abdelhamid S; Vecsei P; Haack D; Gless KH; Walb D; Fiegel P; Lichtwald K
J Steroid Biochem; 1981 Sep; 14(9):913-20. PubMed ID: 7029142
[No Abstract] [Full Text] [Related]
4. Estimation of free urinary aldosterone and 18-hydroxycorticosterone by a combination of automatic high-performance liquid chromatography and radioimmunoassay.
Schöneshöfer M; Weber B; Dulce HJ; Belkien L
J Chromatogr; 1982 Feb; 227(2):492-6. PubMed ID: 7061659
[No Abstract] [Full Text] [Related]
5. Urinary free 18-hydroxycorticosterone, plasma aldosterone, and urinary aldosterone metabolites in normal pregnancy.
Bauknecht H; Vecsei P; Endres H; Hettenbach A
Am J Obstet Gynecol; 1982 Sep; 144(1):28-34. PubMed ID: 7114109
[TBL] [Abstract][Full Text] [Related]
6. The prediction of anatomical morphology of primary aldosteronism using serum 18-hydroxycorticosterone levels.
Kem DC; Tang K; Hanson CS; Brown RD; Painton R; Weinberger MH; Hollifield JW
J Clin Endocrinol Metab; 1985 Jan; 60(1):67-73. PubMed ID: 3964794
[TBL] [Abstract][Full Text] [Related]
7. Aldosterone metabolites and possible aldosterone precursors in hypertension.
Vecsei P; Abdelhamid S; Mittelstädt GV; Lichtwald K; Haack D; Lewicka S
J Steroid Biochem; 1983 Jul; 19(1A):345-51. PubMed ID: 6887870
[TBL] [Abstract][Full Text] [Related]
8. A LC-MS/MS method for the simultaneous quantitative determination of aldosterone, its precursor 18-hydroxycorticosterone and its metabolite tetrahydroaldosterone in human urine.
Dong H; Hu B; Chen W; Wang L; Sun H; Zhou J; Chen J; Chen B; Du Z
J Chromatogr B Analyt Technol Biomed Life Sci; 2024 Feb; 1234():124012. PubMed ID: 38280362
[TBL] [Abstract][Full Text] [Related]
9. [Clinical significance of serum and urinary 18-hydroxycorticosterone analysis in endocrine tests of the adrenal cortex].
Minato M; Honda M; Hatano M
Nihon Rinsho; 1989 Dec; 48 Suppl():1227-30. PubMed ID: 2560070
[No Abstract] [Full Text] [Related]
10. Dopamine reduces aldosterone and 18-hydroxycorticosterone response to angiotensin II in patients with essential low-renin hypertension and idiopathic hyperaldosteronism.
Witzgall H; Lorenz R; von Werder K; Weber PC
Clin Sci (Lond); 1985 Mar; 68(3):291-9. PubMed ID: 3882312
[TBL] [Abstract][Full Text] [Related]
11. Response of aldosterone and 18-hydroxycorticosterone to angiotensin II in normal subjects and patients with essential hypertension, Conn's syndrome, and nontumorous hyperaldosteronism.
Fraser R; Beretta-Piccoli C; Brown JJ; Cumming AM; Lever AF; Mason PA; Morton JJ; Robertson JI
Hypertension; 1981; 3(3 Pt 2):I87-92. PubMed ID: 7262982
[TBL] [Abstract][Full Text] [Related]
12. Increased excretion of 18-hydroxycorticosterone in patients with adrenal adenomas and hypertension.
Vecsei P; Abdelhamid S; Haack D; Lichtwald K; Lewicka S; von Mittelstädt G
Clin Exp Hypertens A; 1982; 4(9-10):1759-70. PubMed ID: 6291815
[TBL] [Abstract][Full Text] [Related]
13. 18, 19-Dihydroxycorticosterone: a new metabolite in human urine.
Godzsa J; Vecsei P; Iwuanyanwu T; Harnik M
Endocr Res; 1989; 15(1-2):151-7. PubMed ID: 2759047
[TBL] [Abstract][Full Text] [Related]
14. Effects of corticotropin-releasing factor (CRF) on aldosterone and 18-hydroxycorticosterone in essential hypertension and primary aldosteronism.
Miyamori I; Yasuhara S; Matsubara T; Okamoto S; Ikeda M; Koshida H; Morise T; Takeda Y; Takeda R; Vecsei P
Endocrinol Jpn; 1987 Dec; 34(6):809-19. PubMed ID: 2836182
[TBL] [Abstract][Full Text] [Related]
15. Dissociation in the excretion of different aldosterone metabolites and unmetabolized ('free') aldosterone in hypertension.
Abdelhamid S; Vecsei P; Haack D; Gless KH; Walb D; Lichtwald K; Fiegel P
Clin Sci (Lond); 1979 Nov; 57(5):409-14. PubMed ID: 519948
[TBL] [Abstract][Full Text] [Related]
16. Urinary excretion of 19-noraldosterone, 18, 19-dihydroxycorticosterone and 18-hydroxy-19-norcorticosterone in patients with aldosterone-producing adenoma or idiopathic hyperaldosteronism.
Takeda Y; Miyamori I; Iki K; Takeda R; Vecsei P
Acta Endocrinol (Copenh); 1992 Jun; 126(6):484-8. PubMed ID: 1642080
[TBL] [Abstract][Full Text] [Related]
17. Confirmatory testing in normokalaemic primary aldosteronism: the value of the saline infusion test and urinary aldosterone metabolites.
Schirpenbach C; Seiler L; Maser-Gluth C; Rüdiger F; Nickel C; Beuschlein F; Reincke M
Eur J Endocrinol; 2006 Jun; 154(6):865-73. PubMed ID: 16728547
[TBL] [Abstract][Full Text] [Related]
18. Determination of urinary 18-hydroxycortisol in the diagnosis of primary aldosteronism.
Miyamori I; Takeda Y; Takasaki H; Itoh Y; Iki K; Takeda R
J Endocrinol Invest; 1992 Jan; 15(1):19-24. PubMed ID: 1560187
[TBL] [Abstract][Full Text] [Related]
19. 18-Hydroxycorticosterone as a marker for primary hyperaldosteronism.
Lapworth R; Short F; James VH
Ann Clin Biochem; 1989 May; 26 ( Pt 3)():227-32. PubMed ID: 2669615
[TBL] [Abstract][Full Text] [Related]
20. The significance of elevated levels of plasma 18-hydroxycorticosterone in patients with primary aldosteronism.
Biglieri EG; Schambelan M
J Clin Endocrinol Metab; 1979 Jul; 49(1):87-91. PubMed ID: 447820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
